graft versus host disease (GVHD) | Page 7 | Aplastic Anemia & MDS International Foundation Return to top.

graft versus host disease (GVHD)

Dr. Eric H. Yang

Yang, Eric
Associate Clinical Professor of Medicine
Ronald Reagan UCLA Medical Center

Dr. Eric Yang is currently an Associate Clinical Professor of Medicine at the Ronald Reagan University of California, Los Angeles Medical Center. He obtained his undergraduate and medical degrees at the University of Illinois at Chicago College of Medicine, and completed his internal medicine residency and cardiology fellowship at Harbor-UCLA Medical Center, where he served as chief fellow.

Dr. Gerard Socie

Socie, Gerard
Head of Hematology
Hospital St. Louis

Gerard Socié, MD, PhD, is the head of the hematology department at Hospital Saint-Louis, APHP. Gerard Socié has a research appointment at the Institut Pasteur -APHP with Dr. Lars Rogge.   His main fields of expertise are transplantation (GvHD),

Epigenetic Aging and Hematopoietic Cell Transplantation in Patients With Severe Aplastic Anemia

Author(s): 
Alsaggaf R, Katta S, Wang T, Hicks BD, Zhu B, Spellman SR, Lee SJ, Horvath S, Gadalla SM
Primary Author: 
Alsaggaf R
Journal Title: 
Transplantation and Cellular Therapy
Original Publication Date: 
Apr 2021

Cellular aging in hematopoietic cell transplantation (HCT) is important in the context of immune reconstitution and age-related complications. Recently, several DNA-methylation (DNAm)-based biomarkers of aging known as "epigenetic clocks" have been introduced as novel tools to predict cellular age.

Transplant Virtual Support Group

Event Date: 
Wed, 02/16/2022 - 5:30pm (EST)

AAMDSIF is pleased to announce that we will host a support group for patients who have been treated with a transplant, or who are considering having a transplant. The group is hosted by AAMDSIF and will be monitored to ensure the privacy and safety of our participants. 

Young Adult Virtual Support Group

Event Date: 
Mon, 11/22/2021 - 7:00pm (EST)

This virtual support group is to help support patients between the ages of 18-30 who have been diagnosed with

Share with addtoany.com.